Terms of Use

1. Agreement to these Terms

These Terms of Use govern access to the Graft pre-launch website and waitlist. By using the site, you agree to these Terms. If you use the site for an organization, you represent that you have authority to bind that organization. If you do not agree, do not use the site.

2. Pre-launch information and availability

The site describes a product under development. Features, security architecture, availability, integrations, pricing, and timelines may change. Joining the waitlist does not guarantee access, a launch date, commercial terms, or any particular feature. We may modify, suspend, or discontinue any part of the site or waitlist at any time.

3. Eligibility and business use

You must be legally able to enter into these Terms and use the site in compliance with applicable law. The site is intended primarily for business and professional evaluation. You are responsible for information submitted through your account, device, or organization.

4. Acceptable use

You may not:

• interfere with or disrupt the site, servers, or security controls;
• probe, scan, or test vulnerabilities without prior written authorization;
• use automated means to scrape the site in a way that burdens the service or violates law;
• submit unlawful, infringing, misleading, or malicious content;
• impersonate another person or misrepresent an affiliation; or
• use the site to develop or distribute malware or facilitate unlawful activity.

For good-faith security reports, contact us.

5. Waitlist communications

When you join the waitlist, you authorize us to send product and early-access communications to the email address you provide. You may unsubscribe at any time. Transactional responses to requests you initiate may still be sent where appropriate.

6. Graft content and intellectual property

The site, including its software, text, visual design, graphics, logo, and other content, is owned by Graft or its licensors and protected by intellectual-property laws. Subject to these Terms, Graft grants you a limited, revocable, non-exclusive, non-transferable right to access the site for internal evaluation. No other rights are granted by implication.

Use of names and marks is also governed by our Trademark Guidelines.

7. Feedback

If you provide ideas, suggestions, or feedback, you grant Graft a worldwide, perpetual, irrevocable, royalty-free right to use and incorporate that feedback without restriction or compensation. This does not transfer ownership of your confidential materials or production data.

8. Third-party services and references

The site may mention or link to third-party products, frameworks, websites, or services. Those references are provided for context and do not imply sponsorship, certification, partnership, or endorsement. Third-party services are governed by their own terms and policies.

9. Disclaimers

To the maximum extent permitted by law, the site and pre-launch information are provided “as is” and “as available,” without warranties of any kind, express or implied, including warranties of merchantability, fitness for a particular purpose, title, non-infringement, availability, or accuracy. Nothing on the site is legal, security, compliance, investment, or professional advice.

10. Limitation of liability

To the maximum extent permitted by law, Graft and its suppliers will not be liable for indirect, incidental, special, consequential, exemplary, or punitive damages, or for loss of profits, data, goodwill, or business opportunity arising from the site or waitlist. Graft’s aggregate liability arising from the pre-launch site will not exceed one hundred U.S. dollars. Some jurisdictions do not allow certain exclusions, so these limits may not apply to you.

11. Changes and termination

We may update these Terms by posting a revised version and changing the effective date. Continued use after an update means you accept the revised Terms. We may restrict or terminate access if we reasonably believe use violates these Terms, threatens security, or creates legal risk.

12. Contact

For questions about these Terms, contact us. Privacy questions are handled under our Privacy Notice.